Thermo Fisher Scientific (Waltham, Massachusetts) announced its collaboration with the Molecular Therapeutics Research Group at the School of Pharmacy, Queen?s University Belfast to analyze peptides in amphibian venom.
Thermo Fisher Scientific (Waltham, Massachusetts) announced its collaboration with the Molecular Therapeutics Research Group at the School of Pharmacy, Queen’s University Belfast to analyze peptides in amphibian venom. The facility is using the company’s LTQ Orbitrap XL mass spectrometer on a trial basis with the goal of expanding its research capabilities for complex peptide identification and de novo sequencing of peptides. The research group currently is focusing its efforts on the isolation, structural characterization, and functional evaluation of novel peptides extracted from amphibian, snake, and arthropod venoms. Research in this area has discovered potential treatment for high blood pressure and possible cures for deep vein thrombosis and heart disease.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.